Breakthroughs
A Promising Obesity Drug with Robert Kushner, MD
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:18:30
- Mas informaciones
Informações:
Sinopsis
The drug semaglutide, typically prescribed for treatment of Type 2 diabetes, was used in a phase 3 clinical trial as a treatment for obesity with very promising results. Northwestern's Robert Kushner, MD, led this study, recently published in the New England Journal of Medicine and shares the results.
